Wikidata

(Q63811743)

English

An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

clinical trial

In more languages

Statements

title
A PHASE 3, MULTI CENTER, OPEN-LABEL EXTENSION STUDY OF ORAL OZANIMOD FOR MODERATELY TO SEVERLY ACTIVE CROHN's DISEASE (English)
0 references
sponsor
Celgene
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Belarus
0 references
Belgium
0 references
Bosnia and Herzegovina
0 references
Brazil
0 references
Bulgaria
0 references
Canada
0 references
Croatia
0 references
Denmark
0 references
Finland
0 references
Georgia
0 references
Germany
0 references
Greece
0 references
Hungary
0 references
Republic of Ireland
0 references
Israel
0 references
Italy
0 references
Latvia
0 references
Lithuania
0 references
Mexico
0 references
Netherlands
0 references
Norway
0 references
Poland
0 references
Portugal
0 references
Romania
0 references
Saudi Arabia
0 references
Serbia
0 references
Slovakia
0 references
Slovenia
0 references
South Africa
0 references
Spain
0 references
Sweden
0 references
Switzerland
0 references
Taiwan
0 references
Turkey
0 references
Ukraine
0 references
United Kingdom
0 references
start time
22 August 2018
0 references
end time
30 December 2022
0 references
number of participants
1,200
0 references
research site
Yale University
0 references
University of Chicago
0 references
Mayo Clinic
0 references
Dartmouth University
0 references
Drug Trials America
0 references
Lenox Hill Hospital
0 references
Ohio State University
0 references
Carilion Clinic
0 references
University of Vienna
0 references
Mount Sinai Hospital
0 references
Peking University
0 references
Wuhan Union Hospital
0 references
Q12338137
0 references
Klinikum Darmstadt
0 references
Kliniken Essen-Mitte
0 references
Shamir Medical Center
0 references
Galilee Medical Center
0 references
Tel Aviv University
0 references
Kaplan Medical Center
0 references
Yonsei University
0 references
Samsung Medical Center
0 references
E-Da Hospital
0 references
Istanbul University
0 references
Cornell University
0 references
Rabin Medical Center
0 references
Marmara University
0 references
minimum age
18 year
0 references
maximum age
75 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63811743&oldid=1857378710"